Walleye Trading’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-239,598
Closed -$50.3K 4188
2024
Q4
$50.3K Buy
239,598
+124,966
+109% +$25.5K ﹤0.01% 3794
2024
Q3
$21.8K Hold
114,632
﹤0.01% 3660
2024
Q2
$24.1K Hold
114,632
﹤0.01% 3750
2024
Q1
$28.7K Hold
114,632
﹤0.01% 4150
2023
Q4
$22.1K Hold
114,632
﹤0.01% 4495
2023
Q3
$30.4K Hold
114,632
﹤0.01% 4317
2023
Q2
$45.3K Hold
114,632
﹤0.01% 3984
2023
Q1
$37.5K Hold
114,632
﹤0.01% 4137
2022
Q4
$28.7K Hold
114,632
﹤0.01% 4314
2022
Q3
$51K Sell
114,632
-1,584
-1% -$935 ﹤0.01% 4232
2022
Q2
$56K Buy
116,216
+10,104
+10% +$5.63K ﹤0.01% 4291
2022
Q1
$65K Buy
+106,112
New +$57.9K ﹤0.01% 4423

Other funds holding DRTSW

Walleye Trading's DRTSW Position: Q1 2025 in Review

Walleye Trading sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2025, closing a stake of 239,598 shares — an estimated $50.3K sold.

Walleye Trading first reported a position in DRTSW in Q1 2022 and held it in 12 quarters. The position peaked at $65K in Q1 2022. 23 funds tracked by Wall St. Rank hold DRTSW as of Q1 2025.

  • Walleye Trading reported no remaining Alpha Tau Medical Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 239,598 Alpha Tau Medical Warrant shares in Q1 2025, an estimated $50.3K.
  • Walleye Trading first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 12 quarters.
  • Walleye Trading's Alpha Tau Medical Warrant position peaked at $65K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.